Literature DB >> 17962032

Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.

Martin L Katz1, Gary S Johnson, Gregory E Tullis, Bo Lei.   

Abstract

Juvenile neuronal ceroid lipofuscinosis (JNCL) is an autosomal recessively inherited neurodegenerative disorder that results from mutations in the CLN3 gene. JNCL is characterized by accumulation of autofluorescent lysosomal storage bodies, vision loss, seizures, progressive cognitive and motor decline, and premature death. Studies were undertaken to characterize the neuronal ceroid lipofuscinosis phenotype in a Cln3 knockout mouse model. Progressive accumulation of autofluorescent storage material was observed in brain and retina of affected mice. The Cln3(-/-) mice exhibited progressively impaired inner retinal function, altered pupillary light reflexes, losses of inner retinal neurons, and reduced brain mass. Behavioral changes included reduced spontaneous activity levels and impaired learning and memory. In addition, Cln3(-/-) mice had significantly shortened life spans. These phenotypic features indicate that the mouse model will be useful for investigating the mechanisms underlying the disease pathology in JNCL and provide quantitative markers of disease pathology that can be used for evaluating the efficacies of therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962032      PMCID: PMC2268761          DOI: 10.1016/j.nbd.2007.08.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  33 in total

1.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice.

Authors:  P Gupta; A A Soyombo; A Atashband; K E Wisniewski; J M Shelton; J A Richardson; R E Hammer; S L Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein.

Authors:  Ruth B Wheeler; Julie D Sharp; Roger A Schultz; John M Joslin; Ruth E Williams; Sara E Mole
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

3.  Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Authors:  Gail M Seigel; Andrew Lotery; Ari Kummer; David J Bernard; Nicholas D E Greene; Mark Turmaine; Todd Derksen; Robert L Nussbaum; Beverly Davidson; Janet Wagner; Hannah M Mitchison
Journal:  Mol Cell Neurosci       Date:  2002-04       Impact factor: 4.314

4.  Membrane topology of CLN3, the protein underlying Batten disease.

Authors:  Qinwen Mao; Brian J Foster; Haibin Xia; Beverly L Davidson
Journal:  FEBS Lett       Date:  2003-04-24       Impact factor: 4.124

5.  Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.

Authors:  Susan L Cotman; Vladimir Vrbanac; Lori-Anne Lebel; Richard L Lee; Kevin A Johnson; Leah-Rae Donahue; Allison M Teed; Kristen Antonellis; Roderick T Bronson; Terry J Lerner; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

6.  Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease.

Authors:  T Bensaoula; H Shibuya; M L Katz; J E Smith; G S Johnson; S K John; A H Milam
Journal:  Ophthalmology       Date:  2000-09       Impact factor: 12.079

7.  Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis.

Authors:  Rebecca M Sappington; David A Pearce; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

8.  The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.

Authors:  Eija Siintola; Meral Topcu; Nina Aula; Hannes Lohi; Berge A Minassian; Andrew D Paterson; Xiao-Qing Liu; Callum Wilson; Ulla Lahtinen; Anna-Kaisa Anttonen; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2007-05-14       Impact factor: 11.025

Review 9.  Current state of clinical and morphological features in human NCL.

Authors:  Hans H Goebel; Krystyna E Wisniewski
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

10.  Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy.

Authors:  Susanna Ranta; Meral Topcu; Saara Tegelberg; Hüseyin Tan; Alp Ustübütün; Isil Saatci; Andreas Dufke; Herbert Enders; Keith Pohl; Yves Alembik; Wayne A Mitchell; Sara E Mole; Anna-Elina Lehesjoki
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

View more
  17 in total

1.  A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Authors:  Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-04-17       Impact factor: 4.797

2.  Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

Authors:  Colleen S Stein; Paul H Yancey; Inês Martins; Rita D Sigmund; John B Stokes; Beverly L Davidson
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

Review 3.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 4.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

5.  Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Haiyan Zheng; Caifeng Zhao; Amenah Soherwardy; Dirk F Moore; Peter Lobel
Journal:  Mol Cell Proteomics       Date:  2019-09-09       Impact factor: 5.911

6.  Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.

Authors:  N S Osório; B Sampaio-Marques; C-H Chan; P Oliveira; D A Pearce; N Sousa; F Rodrigues
Journal:  Genes Brain Behav       Date:  2009-02-19       Impact factor: 3.449

Review 7.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

8.  Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system.

Authors:  John F Staropoli; Larissa Haliw; Sunita Biswas; Lillian Garrett; Sabine M Hölter; Lore Becker; Sergej Skosyrski; Patricia Da Silva-Buttkus; Julia Calzada-Wack; Frauke Neff; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Thure Adler; Oliver Puk; Minxuan Sun; Jack Favor; Ildikó Racz; Raffi Bekeredjian; Dirk H Busch; Jochen Graw; Martin Klingenspor; Thomas Klopstock; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Edith Lopez; Hayat Harati; Eric Hill; Daniela S Krause; Jolene Guide; Ella Dragileva; Evan Gale; Vanessa C Wheeler; Rose-Mary Boustany; Diane E Brown; Sylvie Breton; Klaus Ruether; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Susan L Cotman
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

10.  Interactions between the juvenile Batten disease gene, CLN3, and the Notch and JNK signalling pathways.

Authors:  Richard I Tuxworth; Valérie Vivancos; Megan B O'Hare; Guy Tear
Journal:  Hum Mol Genet       Date:  2008-11-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.